STEPHEN DAVIS Insider Trading $HRTX HERON THERAPEUTICS, INC. /DE/
Get free email notifications about insider trading for STEPHEN DAVIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN DAVIS. STEPHEN DAVIS is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Exec. VP, Chief Oper. Officer in NEUROGEN CORP ($NRGN) and President in NEUROGEN CORP ($NRGN) and President, CEO in NEUROGEN CORP ($NRGN) and Sr VP, Chief Business Officer in NEUROGEN CORP ($NRGN) and Sr VP, Chief Operating Officer in NEUROGEN CORP ($NRGN) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and INTERIM CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and PRESIDENT AND CEO in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
STEPHEN DAVIS in HERON THERAPEUTICS, INC. /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEPHEN DAVIS: Director
Holdings: 3,000 shares
Latest Transaction: Dec 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN DAVIS in HERON THERAPEUTICS, INC. /DE/
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, BLCM, HRTX, NRGN, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2020 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 19.46 | 18,000 | 350,280 | 18,000 | |
| Dec 23 2020 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Oct 15 2020 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 15.72 | 765 | 12,026 | 765 | |
| Apr 17 2020 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 14.44 | 1,426 | 20,591 | 1,426 | |
| Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 25.02 | 15,500 | 387,810 | 15,500 | |
| Oct 01 2019 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 17.56 | 750 | 13,170 | 750 | |
| Oct 01 2019 | HRTX | HERON THERAPEUTICS ... | DAVIS STEPHEN | Director | Option Exercise | A | 17.56 | 25,000 | 439,000 | 25,000 |
Page: 1